← Eichor
Condition: Hereditary Malignant Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Malignant Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07400224AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05010031Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT01109420Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
NA · 1 location(s) · Columbia University · NCT07195071Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06198296Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00001238Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
NA · 5 location(s) · Weill Medical College of Cornell University · NCT07052266A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Phase N/A · 8 location(s) · Maastricht University Medical Center · NCT05463757Institution of an Italian Registry and Biobank for Biological Sample Collection
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06892964Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Phase N/A · 1 location(s) · David M. Ritter · NCT06160310Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · 60 location(s) · Novartis Pharmaceuticals · NCT05948943Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · 3 location(s) · Mayo Clinic · NCT02958462Natural History of Familial Carcinoid Tumor
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00646022Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT06096688InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combine
Phase 2 · 2 location(s) · Franziska Wachter · NCT05796570Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Ex
Phase 1/Phase 2 · 5 location(s) · Kidney Cancer Research Bureau · NCT07292168Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
Phase 1 · 4 location(s) · Tyra Biosciences, Inc · NCT06160752Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06194669Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Phase N/A · 3 location(s) · Proteocyte Diagnostics Inc. · NCT04622462Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
Phase N/A · 1 location(s) · Oscar Gerardo Arrieta Rodríguez · NCT06181812Pancreas Registry and High Risk Registry
Phase N/A · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT02775461
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.